Evaluation of liver function post COVID –19 recovery

Abstract

The 2019 novel coronavirus disease (COVID-19) outbreak began in Wuhan, China, in December 2019 and has since spread across the world as a major epidemic. SARS-CoV-2 (severe acute respiratory syndrome coronavirus -2) is the virus that causes this disease. The respiratory system is greatly affected by the Coronavirus, which is the most common. It has been observed that SARS-2 harms many organs of the body. The aim of this study was performed to evaluate the concentration of liver function tests post COVID-19 patients’ recovery. Patients and Methods This cross-sectional controlled study was conducted in Kirkuk city, the study included 60 patients who were selected randomly 2-3 months after recovery from COVID-19 disease, All patients were PCR +ve previously hospitalized with oxygen therapy. The control group consist of 60 persons who were apparently normal with no severe chronic illness. The result the level of the studied parameter (ALT, AST, TSB) significantly increases (p <0.05) by mean (17.25), (24,60), (0.57) respectively when compared with control group by mean (13.57), (15.54), (0.445). Conclusion the present study revealed a significant difference in the recovery for the ALT, AST, and TSB when compared with healthy group.